Starling Oncology, Inc. Warrant
STLNW
11 hedge funds and large institutions have $479K invested in Starling Oncology, Inc. Warrant in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
42% less capital invested
Capital invested by funds: $821K → $479K (-$342K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$399 |
| 2 |
CS
Clear Street
New York
|
+$19 |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$19 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OMC
1
Oasis Management Company
Grand Cayman,
Cayman Islands
| $307K | – | – | – |
|
|
LP
2
LMR Partners
London,
United Kingdom
| $71K | – | – | – |
|
|
DM
3
Deerfield Management
New York
| $54.8K | – | – | – |
|
|
DKCM
4
Davidson Kempner Capital Management
New York
| $17.7K | – | – | – |
|
|
5
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $8.26K | +$19 | +200 | +0.1% |
|
|
WAM
6
Wolverine Asset Management
Chicago,
Illinois
| $8.12K | +$399 | +4,145 | +2% |
|
7
Man Group
London,
United Kingdom
| $4.94K | – | – | – |
|
8
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
| $4.87K | – | – | – |
|
|
AGM
9
Alpine Global Management
New York
| $1.39K | – | – | – |
|
|
TCM
10
Tenor Capital Management
New York
| $1.09K | – | – | – |
|
|
CS
11
Clear Street
New York
| $273 | +$19 | +200 | +3% |
|
STLNW Hedge Fund Activity: Q1 2026 in Review
11 of the 8,150 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology, Inc. Warrant (STLNW) for Q1 2026, worth a combined $479K — down 42% from $821K a quarter earlier.
Fund positioning in STLNW was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $399.
- 11 institutional investors held Starling Oncology, Inc. Warrant (STLNW) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $479K of Starling Oncology, Inc. Warrant stock for Q1 2026, down 42% quarter-over-quarter.
- 0 funds opened new Starling Oncology, Inc. Warrant positions in Q1 2026 and 0 closed out.
- The largest Starling Oncology, Inc. Warrant buyer in Q1 2026 was Wolverine Asset Management, an estimated $399 added.
Based on aggregated 13F filings for Q1 2026.